Colon Cancer Recurrence Detected by Genetic Test

A team of researchers at Johns Hopkins University and the University of Melbourne found that a specific genetic mutation, detected in DNA circulating in the blood, was associated with cancer recurrence among patients with stage 2 colon cancer. If validated, the test has the potential to help clinicians individualize cancer care by predicting which patients are candidates for added treatment.

The full story can be found here.

To learn about measures being developed by Hopkins inHealth researchers to better predict a range of diseases, click here.

Editor’s Note: We welcome comments, but ask that they remain civil and on-topic. We reserve the right to remove any inappropriate comments.

Join Our Mailing List:

Please enter the word you see in the image below: